Loading interface...

Carbokem Novo 450 MG Injection

Manufactured byAlkem Laboratories Ltd.
ContainsCarboplatin
Description
Carbokem Novo 450 MG Injectionis an anticancer medicine that is used in the treatment of ovarian cancer (cancer of the ovary, part of the female reproductive organs that produces eggs) and lung cancer. This medicine works by preventing the growth of cancer cells by damaging the genetic material (DNA and RNA) which is required for their growth and development. Carbokem Novo 450 MG Injection causes side effects like nausea, vomiting, temporary hair loss, pain, and weakness. This medicine may decrease the number of blood cells (red and white blood cells) in your body, making you more susceptible to infections or bleeding. Inform your doctor if you experience a fever, sore throat, chills, unusual bleeding or bruises, or dark urine. Carbokem Novo 450 MG Injection is given by a qualified medical practitioner, therefore do not self-administer. Your doctor will determine the appropriate dose and duration of the therapy. This can vary depending on the severity of your condition. It may take many weeks or months for you to notice or feel the effects, but do not stop taking it until your doctor advises you to do so. Carbokem Novo 450 MG Injection can affect your heart, liver, and kidney adversely. Inform your doctor if you have any heart, liver, or kidney problems before starting this medicine. You should also inform your doctor if you are pregnant, planning a pregnancy, or are breastfeeding.

Side effects

Major & minor side effects for Carbokem Novo 450 MG Injection

  • Low blood cell count
  • Abnormal Liver function
  • Pain at the injection site
  • Temporary Hair Loss
  • Muscle pain or weakness
  • Blood in urine and stools
  • Tingling or numbness of the hands and feet
  • Blurred vision
  • Ringing or buzzing in the ears
  • Black or Tarry stools
  • Cough or hoarseness

Uses of Carbokem Novo 450 MG Injection

What is it prescribed for?

  • Ovarian Cancer
  • Small Cell Lung Cancer
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    It takes 15 minutes to an hour for Carbokem Novo 450 MG Injection to start its action. It may take longer if it is given along with some other medicines.
  • How long do the effects of this medicine last?
    Carbokem Novo 450 MG Injection remains active in your body for around 24 to 36 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Avoid or limit the consumption of alcohol while you are on therapy with Carbokem Novo 450 MG Injection. Alcohol can cause severe side effects when taken along with this medicine.
  • Is this a habit forming medicine?
    No habit forming tendencies were reported for Carbokem Novo 450 MG Injection.
  • Can this medicine be taken during pregnancy?
    Treatment with Carbokem Novo 450 MG Injection is not recommended during pregnancy as it may be harmful to the foetus. Inform your doctor if you are pregnant and discuss the risk and benefits of this medicine in pregnancy.
  • Can this medicine be taken while breast-feeding?
    It is not known if Carbokem Novo 450 MG Injection passes into breastmilk. Hence, you should stop breastfeeding while on therapy with medicine to avoid harmful effects on the infant.

Allergy

Do not take the treatment if you are allergic to Carbokem Novo 450 MG Injection or other platinum-containing compounds. Seek immediate medical attention if you experience any allergic reactions such as skin rashes, hives (painful eruptions that itch and sting), swelling (face, lips, tongue, etc.), breathing difficulty, etc after undergoing treatment Carbokem Novo 450 MG Injection.

Anaemia

Carbokem Novo 450 MG Injection is known to cause severe myelosuppression (decrease in bone marrow activity which leads to a reduction in blood cells) as well as dose-dependent thrombocytopenia [decrease in blood platelets (blood cells responsible for clot formation) count]. Treatment with Carbokem Novo 450 MG Injection is not recommended in patients with anaemia as it can worsen their condition. If you experience any signs or symptoms of bleeding, such as petechiae (red, brown spots o the skin surface), purpura (purple or black spots due to bleeding under the skin), epistaxis (nose bleeding), etc., report to your doctor as soon as possible.

Severe myelosuppression

Severe myelosuppression is a decrease in bone marrow activity which leads to a reduction in blood cells count. Carbokem Novo 450 MG Injection is not recommended if you have myelosuppression as it can worsen your condition and may lead to leukopenia (low white blood cell count), thrombocytopenia (low platelet count) and anaemia (low red blood cell count).
Warnings for special population

Pregnancy

Treatment with Carbokem Novo 450 MG Injection is not recommended during pregnancy as it may be harmful to the foetus. Inform your doctor if you are pregnant and discuss the risk and benefits of this medicine in pregnancy.

Breast-feeding

It is not known if Carbokem Novo 450 MG Injection passes into breastmilk. Hence, you should stop breastfeeding while on therapy with medicine to avoid harmful effects on the infant.
General warnings

Impaired kidney function

Carbokem Novo 450 MG Injection is excreted via the kidney. Take this medicine with caution if you have severely damaged kidneys.

Hearing impairment

Carbokem Novo 450 MG Injectionmay cause hearing problems which is more common in children. It is advised to get audiometric testing (a test to know the ability to hear sounds) done before initiating the treatment and also before every dose. If you experience any hearing problems, inform your doctor.

Allergy

Carbokem Novo 450 MG Injection may cause serious skin reactions. Inform your doctor about the symptoms and discontinue the treatment.

Driving or operating heavy machines

Carbokem Novo 450 MG Injection may cause blurred vision or dizziness. If you experience any of these symptoms while taking this medication, it is recommended that you avoid doing any activities that require focus such as driving or operating machines.

Infections

Carbokem Novo 450 MG Injection weakens your immune system and increases the risk of infection. Hence, if you have any infection during treatment with Carbokem Novo 450 MG Injection, inform your doctor about it. Your doctor may put the chemotherapy on hold till the infection is settled.

Missed Dose

Carbokem Novo 450 MG Injection is administered in the hospital setting by a qualified healthcare professional, thus the chances of missing a dose are very less. If you miss an appointment for a dose of this medicine, contact your doctor immediately and schedule the dose as soon as possible.

Overdose

Since Carbokem Novo 450 MG Injection is administered in a hospital setting by a qualified healthcare professional, the possibility of an overdose is quite low. If an overdose is suspected, the doctor will initiate emergency medical treatment.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Avoid or limit the consumption of alcohol while you are on therapy with Carbokem Novo 450 MG Injection. Alcohol can cause severe side effects when taken along with this medicine.
Interaction with Medicine

Clozapine

Vancomycin

Atorvastatin

Live vaccines

Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
Carbokem Novo 450 MG Injection is given in multiple cycles. The medicine is administered in a proper healthcare setting by specialized healthcare professionals. It is important to receive each planned dose and to keep track of the next scheduled dose. Keep close monitoring of blood cells count and kidney function.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

May cause sleepiness

How it works
Carbokem Novo 450 MG Injection works by preventing the growth of cancer cells by damaging the genetic material (DNA and RNA) which is required for their growth and development.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Alkylating agents, Anticancer drug

Schedule

Schedule H

Pubchem.ncbi.nlm.nih.gov. 2021. Carboplatin. [online] Available at: < [Accessed 15 July 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/426756>

Drugs, H., 2021. Carboplatin Injection: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 15 July 2021].

https://medlineplus.gov/druginfo/meds/a695017.html>

Dailymed.nlm.nih.gov. 2021. DailyMed - CARBOPLATIN- carboplatin injection, solution. [online] Available at: < [Accessed 15 July 2021].

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b4fa7aac-c9d2-4af4-a281-3e6cfc502ff6>

Medicines.org.uk. 2021. Carboplatin 10 mg/ml Intravenous Infusion - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 3 August 2021].

https://www.medicines.org.uk/emc/product/3787/smpc>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 17 Sep 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.